or
forgot password
  • cancer clinical trials in ashland, KY

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Breast Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Our Lady of Bellefonte Hospital Inc.
    Ashland, Kentucky 41101
    Alzheimer Disease
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Breast Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Our Lady Bellefonte Hospital
    Ashland, Kentucky 41101
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Our Lady Bellefonte Hospital
    Ashland, Kentucky 41101
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    King's Daughter's Medical Center
    Ashland, Kentucky 41101
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
    Research Site
    Ashland, Kentucky
    Bone Metastases in Subjects With Advanced Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Our Lady Bellefonte Hospital

    Trial Locations
    Our Lady Bellefonte Hospital
    King's Daughter's Medical Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Cancer Care at Our Lady of Bellefonte Hospital

    Trial Locations
    Cancer Care at Our Lady of Bellefonte Hospital
    Cancer Resource Center at King's Daughters Medical Center
    Breast Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Ashland, Kentucky
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Our Lady Bellefonte Hospital
    Ashland, Kentucky 41101
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Our Lady Bellefonte Hospital
    Ashland, Kentucky 41101
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
    Research Site
    Ashland, Kentucky
    Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer, Rectal Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Cancer Care at Our Lady of Bellefonte Hospital
    Ashland, Kentucky 41101
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
    1199.14.1079 Boehringer Ingelheim Investigational Site
    Ashland, Kentucky
    Carcinoma, Non-Small-Cell Lung
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Ashland, Kentucky
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Ashland, Kentucky
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
    Kings Daughters Medical Center
    Ashland, Kentucky 41101
    Peripheral Vascular Disease
    Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
    Research Site
    Ashland, Kentucky
    Cancer, Hematologic Malignancies, Multiple Myeloma, Oncology, Bone Metastases, Multiple Myeloma Bone Lesions
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Ashland, Kentucky 41101
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Ashland, Kentucky 41101
    Muscle Wasting, Non-Small Cell Lung Cancer
    Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
    Research Site
    Ashland, Kentucky
    Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenic Purpura
    Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer
    Research Site
    Ashland, Kentucky
    Non Small Cell Lung Cancer
    NOLAN: Naproxen or Loratadine and Neulasta
    Research Site
    Ashland, Kentucky
    Bone Pain in Stage I - III Breast Cancer
    Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
    Cancer Care at Our Lady of Bellefonte Hospital
    Ashland, Kentucky 41101
    Endometrial Cancer, Sarcoma
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Cancer Care at Our Lady of Bellefonte Hospital
    Ashland, Kentucky 41101
    Melanoma (Skin)
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    Cancer Resource Center at King's Daughters Medical Center
    Ashland, Kentucky 41101
    Ovarian Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    King's Daughters Medical Center
    Ashland, Kentucky 41101
    Breast Cancer
    Iressa Expanded Access Program (EAP)
    Research Site
    Ashland, Kentucky
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Cancer Care at Our Lady of Bellefonte Hospital
    Ashland, Kentucky 41101
    Pancreatic Cancer
    Iressa Versus Docetaxel (Taxotere)
    Research Site
    Ashland, Kentucky
    Non-Small-Cell Lung Carcinoma
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Ashland, Kentucky
    Colorectal Cancer, Metastases
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Ashland, Kentucky
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
    Research Site
    Ashland, Kentucky
    Squamous Cell Carcinoma of the Head and Neck
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Ashland, Kentucky
    Refractory Melanoma
    Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
    Research Site
    Ashland, Kentucky
    Lung Cancer, Chemotherapy-Induced Thrombocytopenia, Non-small Cell Lung Cancer, Cancer, Lung Neoplasms, Oncology, Solid Tumors, Thrombocytopenia
    Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
    Research Site
    Ashland, Kentucky
    Cancer of Pancreas, Cancer of the Pancreas, Pancreas Cancer, Pancreatic Cancer
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Ashland, Kentucky
    Non-metastatic Prostate Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    King's Daughter's Medical Center
    Ashland, Kentucky 41101
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes